BIT 0.00% 2.8¢ biotron limited

Research and Dev COVID-19, page-8

  1. 42 Posts.
    lightbulb Created with Sketch. 11
    • Publication number: 20200093796
      Abstract: The present invention relates to the treatment or prevention of influenza virus infection. In particular, the present invention relates to the use of N-carbamimidoyl-5-(1-methyl-1H-pyrazol-4-yl)-2-naphthamide, or a pharmaceutically acceptable salt thereof, in the treatment or prevention of influenza virus infection.
      Type: Application
      Filed: February 7, 2018
      Publication date: March 26, 2020
      Applicant: Biotron Limited
      Inventors: Gary Ewart, Carolyn Luscombe




 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
2.8¢
Change
0.000(0.00%)
Mkt cap ! $25.26M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 312047 2.6¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 42000 1
View Market Depth
Last trade - 11.07am 30/08/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.